Skip to Content
Local Health

Moderna testing HIV vaccine with COVID technology

By
Published 1:57 PM

(KYMA, KECY) - Moderna says the clinical trial for its experimental HIV vaccine is underway using technology from its COVID-19 vaccine.

The pharmaceutical company says participants in phase one of the trial have been vaccinated.

The trial follows 56 people who tested negative for the virus that causes AIDS and studies if the vaccine is safe and effective.

Moderna says the experimental doses utilize the company's MRNA technology.

Researchers hope it can deliver HIV-specific antigens to the body that will induce a positive immune response.

The company says the vaccine appeared to work in 97% of participants in last year's proof of concept trial

Article Topic Follows: Local Health

Jump to comments ↓

Author Profile Photo

April Hettinger

April was born and raised in San Diego where she loved the beach town and her two dogs, Lexi and Malibu. She decided to trade the beach for the snow and advanced her education at Northern Arizona University in Flagstaff.

BE PART OF THE CONVERSATION

KYMA KECY is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content